The White House said the agreements will reduce costs to treat Parkinson's disease, macular degeneration, glaucoma, liver disease and other illnesses.
<iframe src="https://statesidedaily.com/embed/cluster/aed19c8ba80fec5f623fbcb2d50c7c9c966b385e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Trump inks deal with 9 pharmaceutical companies to lower drug costs"></iframe>
The White House said the agreements will reduce costs to treat Parkinson's disease, macular degeneration, glaucoma, liver disease and other illnesses.
